>
The U.S. federal regulation that addresses electronic records and signatures is important for medtech companies with FDA-regulated products. For these companies 21 CFR Part 11 impacts every document, process, and submission. Read our free regulatory brief for a background on the regulation and how medtech companies can achieve compliance.
More infoWatch ReplayGet the ebookGet the briefGet the case studyGet the data sheetGet the webinarGet the video